Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Table 5 Anthropometric measurements (ITT) at different control times (T1 baseline and, T5, T9, T13) in groups treated with PG and O

Variable	Group	T1^a	T4^a	T9^a	T13^a
Weight (kg)	polyglucosamine	100.6 ± 13.22	97.2 ± 12.37	95.6 ± 12.54	94.3 ± 13.06
Weight (kg)	orlisat	98.2 ± 11.47	95.5 ± 11.25	94.9 ± 11.99	93.6 ± 11.88
BMI (kg/m²)	polyglucosamine	34.6 ± 3.70	33.5 ± 3.62	32.9 ± 3.61	32.5 ± 3.69
BMI (kg/m²)	orlistat	34.8 ± 4.73	33.8 ± 4.60	33.6 ± 4.69	33.1 ± 4.66
WC (cm)	polyglucosamine	112.4 ± 10.95	109.2 ± 11.46	107.4 ± 11.25	105.1 ± 11.21
WC (cm)	orlistat	110.0 ± 10.38	107.4 ± 9.98	104.8 ± 9.93	104.1 ± 9.84

ISSN: 2052-9538